Table 2 Mean and SEM values and control adjusted changes for the apolipoproteins ApoB48, ApoC3 and ApoE in serum from the NHPs at baseline and during treatment with the omega-3 rich phospholipid preparation. Dose levels of the administered phospholipids, EPA, DHA and choline are given at the end of the table

ApoB48 (mg/dL)

Control

Mean

1.84

1.86

1.96

1.77

1.84

1.84

1.97

1.96

1.84

2.00

1.95

1.81

1.93

SEM

0.06

0.05

0.04

0.17

0.12

0.20

0.06

0.07

0.15

0.05

0.08

0.12

0.16

Treated

Mean

2.19

2.42

2.17

2.23

2.37

2.25

2.39

2.42

2.27

2.47

2.22

2.61

2.60

SEM

0.21

0.12

0.31

0.05

0.30

0.19

0.31

0.20

0.15

0.07

0.37

0.15

0.10

-

10

−8

7

8

3

1

4

4

5

−7

22

15

ApoC3 (ng/mL)

Control

Mean

50.7

62.3

42.5

37.0

40.9

46.2

48.2

39.9

56.9

44.2

28.9

42.2

38.0

SEM

14.5

10.1

3.17

5.40

10.9

15.1

12.0

17.9

18.3

11.4

11.9

17.9

20.4

Treated

Mean

45.8

33.6

31.3

21.2

21.4

18.7

18.2

13.4

40.7

28.0

30.2

12.5

14.1

SEM

21.9

20.0

18.7

13.2

13.8

10.5

7.70

10.9

21.0

13.4

21.7

4.85

5.42

-

−71

−34

−40

−44

−57

−56

−51

−26

−34

−1

−45

−31

ApoE (ng/mL)

Control

Mean

1.06

1.63

1.20

1.23

1.26

1.99

1.15

1.13

1.36

1.36

1.29

1.59

1.32

SEM

0.12

0.24

0.19

0.27

0.07

0.40

0.18

0.10

0.19

0.09

0.17

0.15

0.05

Treated

Mean

1.68

1.84

1.72

1.44

2.12

2.37

1.95

2.72

1.73

2.61

2.88

2.41

2.67

SEM

0.19

0.34

0.27

0.14

0.28

0.62

0.36

0.57

0.30

0.62

0.99

0.50

0.65

0

−42

−10

−30

6

−46

10

54

−25

23

70

4

29